PT. RICHMOND, Calif., March 13 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced it will report results for its fourth quarter 2008 on Monday, March 23, 2009, after market close.
A conference call to review the results will begin at 5:00 p.m. ET (2:00 p.m. PT) on March 23, 2009 and will be hosted by Glenn A. Oclassen, President & Chief Executive Officer, G Kirk Raab, Chairman, Thomas P. Soloway, Senior Vice President & Chief Financial Officer, and Terrence Moore, Vice President, Marketing & Sales.
To participate in the conference call, please dial 877-795-3610 (USA) or 719-325-4764 (International). In addition, a dial-up replay of the conference call will be available beginning March 23, 2009 at 8:00 p.m. ET (5:00 p.m. PT) and ending on April 6, 2009. The replay telephone number is 888-203-1112 (USA) or 719-457-0820 (International), Replay Passcode: 7416010.
A live webcast of the call will also be available from the Investors section on the corporate web site at www.transcept.com. A webcast replay can be accessed on the corporate web site beginning March 23, 2009 at the same time as the conference call and will remain on the site for two weeks ending April 6, 2009.
About Transcept Pharmaceuticals
Transcept Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. On January 30, 2009, Transcept completed a merger with Novacea, Inc. As part of the transacti
|SOURCE Transcept Pharmaceuticals, Inc.|
Copyright©2009 PR Newswire.
All rights reserved